A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy ad... by Keitel, W.A, Potter, G.E, Diemert, D, Bethony, J, El Sahly, H.M, Kennedy, J.K, Patel, S.M, Plieskatt, J.L, Jones, W, Deye, G, Bottazzi, M.E, Hotez, P.J, Atmar, R.L

Get full text

Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis by Keitel, W.A, Voronca, D.C, Atmar, R.L, Paust, S, Hill, H, Wolff, M.C, Bellamy, A.R

Get full text

Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons ≥65 years old by Keitel, W.A, Treanor, J.J, El Sahly, H.M, Gilbert, A, Meyer, A.L, Patriarca, P.A, Cox, M.M

Get full text

Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans by El Sahly, H.M, Atmar, R.L, Patel, S.M, Wells, J.M, Cate, T, Ho, M, Guo, K, Pasetti, M.F, Lewis, D.E, Sztein, M.B, Keitel, W.A

Get full text

Investigators’ Perspectives on Translating Human Microbiome Research into Clinical Practice by Slashinski, M.J., Whitney, S.N., Achenbaum, L.S., Keitel, W.A., McCurdy, S.A., McGuire, A.L.

Get full text

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1 19) and T helper epitopes of tet... by Keitel, W.A, Kester, K.E, Atmar, R.L, White, A.C, Bond, N.H, Holland, C.A, Krzych, U, Palmer, D.R, Egan, A, Diggs, C, Ballou, W.R, Hall, B.F, Kaslow, D

Get full text